Changes in Composition to Committeess
CLINUVEL PHARMACEUTICALS LTD today announced changes to the composition of its Audit & Risk Committee and to its Remuneration Committee.
Consequent to his retirement from the Board of Directors, Stan McLiesh will be replaced by Jeffrey Rosenfeld on the Audit & Risk Committee as a voting member.
Sue Smith and Karen Agersborg will join the Remuneration Committee as voting members, replacing Stan McLiesh and replacing the Chief Executive Officer, Philippe Wolgen.
These Committees are fully represented by non-executive Directors.